Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland

M. Brändle; M. Azoulay; R.-A. Greiner

doi:10.5414/cpp45203

Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp45203 ◽

2007 ◽

Vol 45 (04) ◽

pp. 203-221 ◽

Cited By ~ 18

Author(s):

M. Brändle ◽

M. Azoulay ◽

R.-A. Greiner

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Cost Utility ◽

Nph Insulin

Download Full-text

PDB1 IMPROVED GLYCAEMIC CONTROL AND LESS HYPOGLYCAEMIA WITH INSULIN GLARGINE COMPARED WITH NPH INSULIN IN PATIENTS WITH TYPE 2 DIABETES LEADS TO FEWER LONG-TERM COMPLICATIONS—RESULTS OF THE DIABETES MELLITUS SIMULATION MODEL

Value in Health ◽

10.1016/s1098-3015(10)61725-1 ◽

2003 ◽

Vol 6 (6) ◽

pp. 674-675

Author(s):

S Maxion-Bergemann ◽

E Müller ◽

R Bergemann ◽

S Walleser ◽

E Huppertz

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Simulation Model ◽

Nph Insulin ◽

Improved Glycaemic Control

Download Full-text

Long-Term Efficacy of Insulin Glargine After Switching from NPH Insulin as Intensive Replacement of Basal Insulin in Japanese Diabetes Mellitus. Comparison of Efficacy between Type 1 and Type 2 diabetes (JUN-LAN Study 1.2)

Endocrine Journal ◽

10.1507/endocrj.k07e-035 ◽

2007 ◽

Vol 54 (6) ◽

pp. 975-983 ◽

Cited By ~ 8

Author(s):

Yoshie KANAZAWA ◽

Yasuhiro IGARASHI ◽

Koji KOMIYA ◽

Yuko SAKURAI ◽

Tomoaki SHIMIZU ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Nph Insulin ◽

Term Efficacy

Download Full-text

The Impact of Long-Term Clinical Evidence on Cost-Effectiveness of Exenatide Once Weekly (Bydureon®) Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus (T2dm) From A Uk Nhs Perspective

Value in Health ◽

10.1016/j.jval.2014.08.689 ◽

2014 ◽

Vol 17 (7) ◽

pp. A343

Author(s):

M. Charokopou ◽

H. Vioix ◽

B.G. Verheggen ◽

T. Bratt ◽

D. Franks

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Clinical Evidence ◽

The Impact

Download Full-text

Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp49217 ◽

2011 ◽

Vol 49 (03) ◽

pp. 217-230 ◽

Cited By ~ 13

Author(s):

M. Brändle ◽

M. Azoulay ◽

R.-A. Greiner

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Glycemic Control ◽

Insulin Glargine ◽

Nph Insulin

Download Full-text

Evaluating The Long-Term Cost-Effectiveness Of Liraglutide 1.2 Mg And Exenatide In Patients With Type 2 Diabetes Mellitus

Value in Health ◽

10.1016/j.jval.2014.08.161 ◽

2014 ◽

Vol 17 (7) ◽

pp. A744-A745

Author(s):

LW Shi ◽

S Han ◽

F LIU

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness

Download Full-text

Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand

Applied Health Economics and Health Policy ◽

10.1007/s40258-016-0228-3 ◽

2016 ◽

Vol 14 (3) ◽

pp. 281-292 ◽

Cited By ~ 4

Author(s):

Unchalee Permsuwan ◽

Nathorn Chaiyakunapruk ◽

Piyameth Dilokthornsakul ◽

Kednapa Thavorn ◽

Surasak Saokaew

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Neutral Protamine Hagedorn

Download Full-text

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Reply to Chantelau E [letter] and Currie CJ [letter]

Diabetologia ◽

10.1007/s00125-009-1492-7 ◽

2009 ◽

Vol 52 (10) ◽

pp. 2236-2239

Author(s):

J. Rosenstock ◽

V. Fonseca ◽

J. B. McGill ◽

M. Riddle ◽

J.-P. Hallé ◽

...

Keyword(s):

Type 2 Diabetes ◽

Diabetic Retinopathy ◽

Insulin Glargine ◽

Open Label ◽

Nph Insulin ◽

Open Label Study ◽

Label Study ◽

Neutral Protamine Hagedorn

Download Full-text

The cost-effectiveness of dulaglutide versus insulin glargine for the treatment of type 2 diabetes mellitus in Japan

Journal of Medical Economics ◽

10.1080/13696998.2018.1431918 ◽

2018 ◽

Vol 21 (5) ◽

pp. 488-496 ◽

Cited By ~ 4

Author(s):

Hitoshi Ishii ◽

Matthew Madin-Warburton ◽

Alena Strizek ◽

Lucy Thornton-Jones ◽

Shuichi Suzuki

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Insulin Glargine ◽

The Cost

Download Full-text

PDB79 - COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA

Value in Health ◽

10.1016/j.jval.2018.09.784 ◽

2018 ◽

Vol 21 ◽

pp. S131-S132

Author(s):

M. Bogdanovic ◽

M. Fournier ◽

D. Vitezic

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Cost Utility ◽

Cost Utility Analysis ◽

Insulin Degludec ◽

Utility Analysis

Download Full-text

Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-on Therapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies

Value in Health ◽

10.1016/j.jval.2015.09.2105 ◽

2015 ◽

Vol 18 (7) ◽

pp. A609

Author(s):

J Deng ◽

S Gu ◽

H Shao ◽

H Dong ◽

Y Zhao ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Cost Effectiveness Analysis ◽

Chinese Patients ◽

Once Daily ◽

Effectiveness Analysis

Download Full-text